Stocktoria

OnKure Therapeutics, Inc. OKUR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-04-09

OnKure Therapeutics, Inc. statistics & valuation

Market cap$181.8M
P / B3.2×
Return on equity-105.9%
Return on capital-112%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-27.00% -50.70% -105.90% 202020212022202320242025
Shares outstanding
2.1M 24.5M 24.7M 3.3M 3.4M 13.5M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-35.20% -25.80% -48.00% -98.80% -45.80% -95.80% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$9.60 -$2.19 -$2.12 -$124.41 -$15.28 -$4.40 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-95.8%-45.8%-98.8%-48.0%-25.8%-35.2%
Return on equity-105.9%-50.7%34.7%95.5%-27.0%46.2%
Current ratio10.2810.734.6414.9324.7912.01

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.